Cargando…

How Does One Diagnose and Manage Severe Community-Acquired Pneumonia?

Detalles Bibliográficos
Autores principales:	Brito, Veronica, Niederman, Michael S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152406/ http://dx.doi.org/10.1016/B978-1-4160-5476-4.00038-9

Ejemplares similares

Severe community-acquired pneumonia
por: Niederman, Michael S., et al.
Publicado: (2022)

Community-acquired pneumonia
por: Niederman, Michael S.
Publicado: (2010)

Updates on community acquired pneumonia management in the ICU
por: Nair, Girish B., et al.
Publicado: (2021)

Viral Community-Acquired Pneumonia: If We Do Not Diagnose It and Do Not Treat It, Can It Still Hurt Us?
por: Niederman, Michael S.
Publicado: (2010)

Community-Acquired Pneumonia: An Unfinished Battle
por: Nair, Girish B., et al.
Publicado: (2011)

Antimicrobial therapy of community-acquired pneumonia
por: File, Thomas M., et al.
Publicado: (2004)

European respiratory monographs: community-acquired pneumonia
por: Niederman, Michael S
Publicado: (2014)

Recent Advances in Community-Acquired Pneumonia: Inpatient and Outpatient
por: Niederman, Michael S.
Publicado: (2007)

PNEUMONIA | Community Acquired Pneumonia, Bacterial and Other Common Pathogens
por: Niederman, M.S.
Publicado: (2006)

Adjuvant therapies in critical care: steroids in community-acquired pneumonia
por: Torres, Antoni, et al.
Publicado: (2017)

Pneumonia Complicating Pregnancy
por: Brito, Veronica, et al.
Publicado: (2011)

Challenges in severe community-acquired pneumonia: a point-of-view review
por: Torres, Antoni, et al.
Publicado: (2019)

Too Much or Too Little Empiric Treatment for Pseudomonas aeruginosa in Community-acquired Pneumonia?
por: Torres, Antoni, et al.
Publicado: (2021)

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

Severe community-acquired pneumonia
por: Morgan, AJ, et al.
Publicado: (2016)

Severe Community-Acquired Pneumonia
por: Khatib, Khalid, et al.
Publicado: (2019)

Severe Community-Acquired Pneumonia
por: Sligl, Wendy I., et al.
Publicado: (2013)

Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study
por: Mahboub, Bassam, et al.
Publicado: (2015)

Lung ultrasonography to diagnose community-acquired pneumonia in children
por: Principi, Nicola, et al.
Publicado: (2017)

Value of syndromic panels in the management of severe community-acquired pneumonia
por: Burillo, Almudena, et al.
Publicado: (2022)

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017)

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

Advances in severe community-acquired pneumonia
por: Wang, Jian, et al.
Publicado: (2019)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Diagnosing Viral and Atypical Pathogens in the Setting of Community-Acquired Pneumonia
por: Waterer, Grant W.
Publicado: (2017)

Factors influencing severity of community-acquired pneumonia
por: Mahendra, M, et al.
Publicado: (2018)

Pneumonia severity index in viral community acquired pneumonia in adults
por: Kim, Mi-Ae, et al.
Publicado: (2019)

Challenges in understanding host genetics and severity of community-acquired pneumonia
por: Solé-Violán, Jordi, et al.
Publicado: (2021)

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
por: Torres, Antoni, et al.
Publicado: (2018)

Telavancin for the treatment of hospital-acquired pneumonia in severely ill and older patients: the ATTAIN studies
por: Rubinstein, E, et al.
Publicado: (2009)

Usefulness of Plasma YKL-40 in Management of Community-Acquired Pneumonia Severity in Patients
por: Wang, Hsiang-Ling, et al.
Publicado: (2013)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Adjunctive immunomodulation in severe community-acquired pneumonia
por: Bradley, James, et al.
Publicado: (2023)

Community-acquired pneumonia infections by Acinetobacter baumannii: How does alcohol impact the antimicrobial functions of macrophages?
por: Eugenin, Eliseo A
Publicado: (2013)

Major advances in managing community-acquired pneumonia
por: Asrar Khan, Waseem, et al.
Publicado: (2013)

Management of community acquired pneumonia by Family Physicians
por: Akhter, Saima, et al.
Publicado: (2017)

2018 recommendations for the management of community acquired pneumonia
por: Corrêa, Ricardo de Amorim, et al.
Publicado: (2018)

Severe community-acquired pneumonia: timely management measures in the first 24 hours
por: Phua, Jason, et al.
Publicado: (2016)

Advancements in the Management of Severe Community-Acquired Pneumonia: A Comprehensive Narrative Review
por: Davis, Don, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5lfifi9l490hkjkvoi9vjjout6